Trial Profile
Ranolazine Mediated Premature Ventricular Contraction Reduction in Ischemic Heart Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Myocardial ischaemia
- Focus Therapeutic Use
- 28 Jan 2020 Status changed from recruiting to completed.
- 01 Sep 2016 Planned End Date changed from 1 Dec 2015 to 1 Sep 2017.
- 01 Sep 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Sep 2017.